MedVellum
MedVellum
Back to Library
Urology
General Practice
Emergency Medicine

Urinary Tract Infection (UTI)

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Sepsis (fever, rigors, hypotension, tachycardia)
  • Pyelonephritis (loin pain, fever, vomiting)
  • Urinary obstruction with infection
  • UTI in pregnancy
  • Recurrent UTI in men
Overview

Urinary Tract Infection (UTI)

1. Clinical Overview

Summary

Urinary tract infection (UTI) is bacterial infection of the urinary tract, divided into lower UTI (cystitis - bladder) and upper UTI (pyelonephritis - kidney). It is one of the most common infections in clinical practice, affecting 50% of women at some point in their lives. Escherichia coli causes 70-90% of community-acquired UTIs. Management depends on classification as uncomplicated or complicated, patient factors, and local resistance patterns. [1,2]

Key Facts

  • Incidence: 150 million cases globally per year. [3]
  • Lifetime Risk (Women): 50-60%; 25% will have recurrence.
  • Common Organism: E. coli (70-90% of uncomplicated UTI).
  • Classification: Lower (cystitis) vs Upper (pyelonephritis); Uncomplicated vs Complicated.
  • Diagnosis: Clinical symptoms + dipstick (nitrites/leucocytes) ± culture.
  • Treatment: Short-course antibiotics for uncomplicated; longer courses for complicated/pyelonephritis.

Clinical Pearls

Nitrites = Gram-Negative Bacteria: Only organisms that reduce nitrate to nitrite (mainly Enterobacteriaceae) give positive nitrite. A negative nitrite does NOT exclude infection (Staph saprophyticus, Enterococcus don't produce nitrite).

Leucocyte Esterase Alone is Non-Specific: Positive leucocytes can occur with sterile pyuria (STI, TB, stones, interstitial nephritis). Send MSU if in doubt.

UTI in Men is Always Complicated: Men have longer urethras and prostatic antibacterial factors. Any UTI should prompt investigation for underlying cause (residual volume, prostate).

Asymptomatic Bacteriuria - When to Treat: ONLY treat in pregnancy and before urological procedures. Do NOT treat in elderly, catheterised, diabetics, or institutionalised patients (no benefit, drives resistance). [4]


2. Epidemiology

Incidence and Demographics

  • Global Burden: 150+ million UTIs annually.
  • Women: Annual incidence 10-15%; lifetime risk 50-60%.
  • Men: Annual incidence less than 1% under 50 years; increases with age (prostatic disease).
  • Peak Age in Women: Young sexually active (18-24) and postmenopausal.
  • Children: 3-5% of girls, 1% of boys by age 10.

Risk Factors

Women

Risk FactorMechanism
Female anatomyShort urethra, proximity to anus
Sexual activity"Honeymoon cystitis"; mechanical introduction
Spermicide useAlters vaginal flora
New sexual partnerDifferent bacterial exposure
PregnancyUreteric dilation, stasis, immunological changes
MenopauseOestrogen deficiency → ↓Lactobacilli
Previous UTISingle strongest predictor of recurrence
DiabetesGlycosuria, immune impairment
Urinary instrumentationCatheters, cystoscopy

Men

Risk FactorMechanism
BPH/Prostatic enlargementIncomplete emptying, residual volume
Prostatic diseaseBacterial reservoir
Urethral strictureObstruction, stasis
CatheterisationDirect bacterial introduction
UncircumcisedSlightly increased colonisation
Age greater than 50Prostatic factors

Causative Organisms

OrganismFrequencyNotes
Escherichia coli70-90%Most common; gut commensal
Klebsiella pneumoniae5-10%Complicated UTI
Proteus mirabilis5-10%Produces urease → struvite stones
Staphylococcus saprophyticus5-15% (young women)Does NOT produce nitrites
Enterococcus faecalis5%Intrinsic resistance to cephalosporins
Pseudomonas aeruginosaHospital/catheterBiofilm formation
Candida speciesCatheterised, diabeticFungal; often colonisation

3. Pathophysiology

Step 1: Bacterial Entry

  • Ascending Route: Most common. Bacteria colonise periurethral area → ascend urethra → bladder.
  • Haematogenous: Rare; seen with S. aureus bacteraemia → renal abscess.
  • Lymphatic: Theoretical.

Step 2: Colonisation

  • Bacterial Adherence: Fimbriae (pili) bind to uroepithelial receptors.
  • Type 1 Fimbriae: Bind mannose; important for cystitis.
  • P-Fimbriae: Bind P-blood group antigens; important for pyelonephritis.
  • Biofilm Formation: Particularly on catheters.

Step 3: Host Response

  • Innate Immunity: Urinary flow (washout), urine pH, antimicrobial peptides (defensins).
  • PRR Activation: Toll-like receptors recognise LPS → cytokine release.
  • Inflammation: Neutrophil recruitment → pyuria.
  • Mucosal Damage: Dysuria, frequency, urgency.

Step 4: Cystitis vs Pyelonephritis

Cystitis (Lower UTI)

  • Infection confined to bladder.
  • Local symptoms only.
  • No systemic involvement.

Pyelonephritis (Upper UTI)

  • Bacteria ascend via ureters to kidney.
  • Parenchymal infection.
  • Systemic inflammatory response (fever, rigors).
  • Risk of abscess, scarring, sepsis.

Step 5: Complicated vs Uncomplicated

UncomplicatedComplicated
Non-pregnant adult femalePregnancy
Normal urinary tract anatomyStructural abnormality
No systemic symptomsMale
No immunocompromiseCatheter-associated
Diabetes
Immunosuppression
Recent instrumentation
Children

4. Clinical Presentation

Lower UTI (Cystitis)

SymptomFrequencyDescription
Dysuria80-90%Burning/stinging on urination
Frequency80%Passing urine more often
Urgency60%Sudden need to urinate
Suprapubic pain50%Lower abdominal discomfort
Haematuria40%Visible or microscopic
Cloudy/offensive urine40%Pyuria, bacteriuria
Nocturia30%Night-time voiding

Upper UTI (Pyelonephritis)

SymptomFrequencyDescription
Fever90%Often high (greater than 38°C), rigors
Loin/flank pain80%Unilateral, may radiate
Nausea/vomiting50-60%Unable to tolerate oral medications
Lower UTI symptoms50%May or may not be present
Costovertebral angle tenderness80%On examination

Special Populations

Elderly

Children

Pregnancy

Red Flags - "The Don't Miss" Signs

  1. Fever, rigors, loin pain → Pyelonephritis; may need IV antibiotics.
  2. Signs of sepsis → Urgent assessment; IV antibiotics within 1 hour.
  3. Unable to tolerate oral intake → Admission for IV therapy.
  4. Retention with infection → Obstructed infected system; urology emergency.
  5. UTI in pregnancy → Higher risk of complications; requires culture.
  6. Recurrent UTI in men → Investigate for underlying cause.

May present atypically
confusion, falls, incontinence, functional decline.
Classical symptoms may be absent.
Common presentation.
High rates of asymptomatic bacteriuria (do NOT treat).
Common presentation.
5. Clinical Examination

General Assessment

  • Temperature (fever suggests upper UTI/sepsis).
  • Heart rate, blood pressure (sepsis assessment).
  • Hydration status.

Abdominal Examination

  • Suprapubic tenderness (cystitis).
  • Loin tenderness, renal angle tenderness (pyelonephritis).
  • Palpable bladder (retention).
  • Abdominal mass (renal abscess).

Specific Tests

Costovertebral Angle (CVA) Tenderness

  • Percussion over the flank at the angle of 12th rib and spine.
  • Pain = suggests pyelonephritis.

Digital Rectal Examination (Men)

  • Prostatic enlargement (BPH).
  • Prostatic tenderness (prostatitis - avoid vigorous examination).

Pelvic Examination (If Indicated)

  • Exclude vaginitis, STI.
  • Particularly if dysuria without frequency.

6. Investigations

Urinalysis

Urine Dipstick

ParameterSignificanceSensitivitySpecificity
NitritesGram-negative organisms45-60%85-98% (high)
Leucocyte EsterasePyuria75-90%65-80%
BloodMay be present in UTINon-specificNon-specific
ProteinMay be presentNon-specificNon-specific

Interpretation

  • Nitrites + Leucocytes: High probability of UTI; treat empirically.
  • Nitrites alone: Supports UTI.
  • Leucocytes alone: May be UTI or other cause (STI, contamination).
  • Both negative: 96% NPV; unlikely UTI (but doesn't exclude).

Mid-Stream Urine (MSU) Culture

When to Send

IndicationRationale
All menUTI in men is complicated
PregnancyNeed to confirm eradication
Treatment failureResistance testing
Recurrent UTIConfirm organism and sensitivity
Complicated UTIGuide antibiotic choice
PyelonephritisConfirm organism
CatheterisedIf symptomatic
Hospital-acquiredHigher resistance rates

Culture Results

  • Significant bacteriuria: at least 10⁵ CFU/mL (symptomatic at least 10³ may be significant).
  • Mixed growth: Usually contamination; repeat if clinical concern.

Blood Tests (Pyelonephritis/Sepsis)

  • FBC: Leucocytosis.
  • U&E: Renal function.
  • CRP: Elevated in pyelonephritis.
  • Blood cultures: If febrile or septic.
  • Lactate: If sepsis suspected.

Imaging (Selected Cases)

InvestigationIndication
Renal ultrasoundObstruction, abscess, failure to respond in 48-72 hours
CT urogramRenal/perinephric abscess, stones
MCUG (children)Vesicoureteric reflux investigation
CystoscopyRecurrent UTI, haematuria, bladder pathology

7. Management

Management Algorithm

           SUSPECTED UTI
                 ↓
┌────────────────────────────────────────┐
│    CLINICAL ASSESSMENT                 │
│  - Symptoms (dysuria, frequency, fever)│
│  - Risk factors (complicated?)         │
│  - Red flags (sepsis, loin pain)       │
└────────────────────────────────────────┘
                 ↓
           URINE DIPSTICK
                 ↓
    ┌────────────┴────────────┐
    ↓                         ↓
POSITIVE               NEGATIVE
(Nitrites/Leucocytes)   (Both negative)
    ↓                         ↓
   TREAT              Consider alternative
                      diagnosis (STI, vaginitis)
    ↓                 Repeat if high suspicion
    ↓
┌───┴───────────────────────────────┐
↓                                   ↓
UNCOMPLICATED                 COMPLICATED
(Healthy non-pregnant         (Men, pregnancy,
woman)                        catheter, pyelonephritis)
    ↓                              ↓
┌──────────────────┐      ┌──────────────────┐
│ - No MSU needed  │      │ - SEND MSU       │
│ - Short course   │      │ - Longer course  │
│   antibiotics    │      │ - Consider       │
│ - First-line:    │      │   admission if   │
│   Nitrofurantoin │      │   severe         │
│   or Trimethoprim │     │                  │
│   (3 days)       │      │                  │
└──────────────────┘      └──────────────────┘

Antibiotic Treatment

Acute Uncomplicated Cystitis in Women (NICE NG109) [5]

AntibioticDoseDurationNotes
Nitrofurantoin100mg MR BD3 daysFirst-line; avoid if eGFR less than 45
Trimethoprim200mg BD3 daysCheck local resistance (greater than 30% in some areas)
Pivmecillinam400mg TDS3 daysAlternative
Fosfomycin3g single doseOnceAlternative

Pyelonephritis (Uncomplicated)

AntibioticDoseDurationNotes
Cefalexin500mg BD-TDS7-10 daysFirst-line oral
Co-amoxiclav625mg TDS7-10 daysAlternative
Ciprofloxacin500mg BD7 daysIf culture supports
IV optionsCefuroxime, Gentamicin7-14 daysIf unable to tolerate oral/severe

Complicated UTI (Men, Catheter, Structural)

AntibioticDoseDurationNotes
Trimethoprim200mg BD7 daysAfter culture result
Nitrofurantoin100mg MR BD7 daysOnly for lower UTI
Ciprofloxacin500mg BD7 daysGood prostate penetration

UTI in Pregnancy [6]

AntibioticDoseDurationNotes
Nitrofurantoin100mg BD7 daysAvoid at term (haemolytic anaemia)
Amoxicillin500mg TDS7 daysIf sensitivity known
Cefalexin500mg BD7 daysSafe throughout pregnancy
AvoidTrimethoprim (1st trimester - folate antagonist), Quinolones

Catheter-Associated UTI (CAUTI)

  • Change catheter before treating (biofilm issue).
  • Treat only if symptomatic (fever, new confusion, suprapubic pain).
  • 7 days antibiotics (guided by culture).

Recurrent UTI Prevention

Behavioural Measures

  • High fluid intake.
  • Post-coital voiding.
  • Avoid spermicides.
  • Wipe front to back.

Prophylaxis Options

StrategyRegimenNotes
Continuous prophylaxisNitrofurantoin 50-100mg nocte6-12 months
Post-coital prophylaxisNitrofurantoin 50-100mg single doseIf sex-related
Self-start therapyPatient-initiated 3-day courseFor infrequent recurrence
Vaginal oestrogenTopical cream/pessaryPostmenopausal women
Cranberry productsJuice or capsulesLimited evidence
Methenamine hippurate1g BDFor prophylaxis; avoid with nitrofurantoin

8. Complications

Complications of UTI

ComplicationRisk FactorsManagement
PyelonephritisDelayed treatment, obstructionIV antibiotics, hydration
Renal abscessDelayed treatment, structural abnormalityDrainage, prolonged antibiotics
Perinephric abscessExtension of renal infectionPercutaneous drainage
Sepsis/UrosepsisObstruction, immunocompromiseSepsis 6, ICU if severe
Renal scarringRecurrent childhood UTIChronic kidney disease
Epididymo-orchitisUTI in menProlonged antibiotics
Preterm labourUTI in pregnancyClose monitoring, treatment

Antibiotic Resistance

  • Rising resistance to trimethoprim (30-40% in some areas).
  • ESBL-producing organisms increasing.
  • Quinolone resistance increasing.
  • Always check local resistance data.

9. Prognosis and Outcomes

Uncomplicated Cystitis

  • Excellent prognosis.
  • Symptoms resolve in 24-48 hours with treatment.
  • Without treatment, 25-45% resolve spontaneously (but risk of progression).

Pyelonephritis

  • Good prognosis if treated promptly.
  • Mortality less than 1% in healthy adults.
  • Higher risk with obstruction, diabetes, immunocompromise.

Recurrence Risk

  • 25-30% of women have recurrence within 6 months.
  • 3+ UTIs per year = recurrent UTI.

Long-Term Outcomes

  • Uncomplicated UTI: No long-term sequelae.
  • Recurrent pyelonephritis: Risk of renal scarring.
  • Paediatric UTI: Investigate for VUR; risk of scarring.

10. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
NICE NG109UKNitrofurantoin first-line, short course, no MSU for uncomplicated
NICE NG224UKUTI in under 16s
SIGN 88ScotlandUTI management in adults
EAU GuidelinesEuropeComplicated UTI and pyelonephritis
IDSA GuidelinesUSAUncomplicated cystitis and pyelonephritis

Landmark Studies

1. IDSA Uncomplicated Cystitis Guidelines (2011) [7]

  • Established trimethoprim-sulfamethoxazole (TMP-SMX) 3 days as benchmark.
  • Nitrofurantoin 5 days equally effective.
  • Fluoroquinolones reserved for resistance.
  • Impact: Standardised treatment approach.
  • PMID: 21292654.

2. Foxman et al. UTI Epidemiology (2000) [3]

  • Characterised risk factors in young women.
  • Sexual activity strongest modifiable risk factor in young women.
  • PMID: 10809801.

3. Asymptomatic Bacteriuria Studies [4]

  • Multiple RCTs show no benefit of treatment in elderly, diabetics, catheterised.
  • Treatment only for pregnancy and pre-urological procedures.
  • Impact: Reduced unnecessary antibiotic use.
  • PMID: 16311099.

11. Patient and Layperson Explanation

What is a UTI?

A urinary tract infection (UTI) is an infection caused by bacteria in any part of your urinary system - the kidneys, ureters, bladder, or urethra. Most UTIs affect the bladder (cystitis) and are easily treated with antibiotics.

Who Gets UTIs?

  • Very common in women (1 in 2 will have one at some point).
  • Less common in men, but can occur (especially with prostate problems).
  • More common in pregnancy, diabetes, and with catheters.

What Are the Symptoms?

Bladder Infection (Cystitis)

  • Burning or stinging when you urinate.
  • Needing to urinate more often.
  • Feeling like you need to go urgently.
  • Pain in your lower tummy.
  • Cloudy or smelly urine.
  • Blood in urine.

Kidney Infection (Pyelonephritis)

  • All of the above PLUS:
  • High fever and chills.
  • Pain in your side or back.
  • Nausea and vomiting.
  • Feeling very unwell.

How is it Diagnosed?

  • Usually from your symptoms and a urine dipstick test.
  • Sometimes a urine sample is sent to the lab.

How is it Treated?

  • Antibiotics: Usually a short course (3 days for simple bladder infections).
  • Drink plenty of fluids.
  • Paracetamol: For pain and fever.
  • Kidney infections: May need longer antibiotics or hospital treatment.

How Can I Prevent UTIs?

  • Drink plenty of water.
  • Don't hold on when you need to urinate.
  • Wipe from front to back after using the toilet.
  • Urinate after sex.
  • Avoid perfumed products near the genital area.
  • If you get frequent UTIs, talk to your doctor about prevention options.

When to Seek Urgent Help

  • High fever or chills.
  • Severe back or side pain.
  • Vomiting and unable to keep fluids down.
  • Blood in urine with fever.
  • Symptoms not improving after 48 hours of antibiotics.
  • Confused or very drowsy (especially elderly).

12. References

Primary Sources

  1. Flores-Mireles AL, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269-284. PMID: 25853778.
  2. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28:1-13. PMID: 24484571.
  3. Foxman B. Epidemiology of urinary tract infections. Clin Infect Dis. 2000;32:13-22. PMID: 10809801.
  4. Nicolle LE, et al. Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clin Infect Dis. 2005;40:643-654. PMID: 15714408.
  5. NICE Guideline NG109. Urinary tract infection (lower): antimicrobial prescribing. 2018. https://www.nice.org.uk/guidance/ng109.
  6. NICE Guideline NG135. Urinary tract infection in pregnancy. 2018.
  7. Gupta K, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clin Infect Dis. 2011;52:e103-e120. PMID: 21292654.

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24

Red Flags

  • Sepsis (fever, rigors, hypotension, tachycardia)
  • Pyelonephritis (loin pain, fever, vomiting)
  • Urinary obstruction with infection
  • UTI in pregnancy
  • Recurrent UTI in men

Clinical Pearls

  • **Leucocyte Esterase Alone is Non-Specific**: Positive leucocytes can occur with sterile pyuria (STI, TB, stones, interstitial nephritis). Send MSU if in doubt.
  • **UTI in Men is Always Complicated**: Men have longer urethras and prostatic antibacterial factors. Any UTI should prompt investigation for underlying cause (residual volume, prostate).

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines